Search Browse Earnings

Enlivex Ltd.

Nasdaq:ENLV

Pharmaceutical Preparations·TEL AVIV

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$25.0M

FY 2024

Net Income

-$31.1M

FY 2024

EPS (Diluted)

-$1.69

FY 2024

Stock Price

$1.04

-2.8%

2026-03-13

52W Range

$0.66 – $2.10

P/E Ratio

-0.6x

Market Cap

$24.6M

Cash

$813,000

FY 2024

Total Debt

—

Net Cash

$813,000

Enterprise Value

$23.8M

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

-1.0x

Employees

—